This is a preview of subscription content, log in via an institution to check access.
Reference
Foo J, et al. Cost-consequence analysis for human recombinant growth hormone (r-hGH) treatment administered via different devices in children with growth hormone deficiency in Italy. ClinicoEconomics and Outcomes Research : 22 Aug 2019. Available from: URL: https://doi.org/10.2147/CEOR.S195265
Rights and permissions
About this article
Cite this article
Somatropin easypod good value in growth-hormone deficiency. PharmacoEcon Outcomes News 836, 26 (2019). https://doi.org/10.1007/s40274-019-6199-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-6199-5